Cite
Shojaie L, Ali M, Iorga A, et al. Mechanisms of immune checkpoint inhibitor-mediated liver injury. Acta Pharm Sin B. 2021;11(12):3727-3739doi: 10.1016/j.apsb.2021.10.003.
Shojaie, L., Ali, M., Iorga, A., & Dara, L. (2021). Mechanisms of immune checkpoint inhibitor-mediated liver injury. Acta pharmaceutica Sinica. B, 11(12), 3727-3739. https://doi.org/10.1016/j.apsb.2021.10.003
Shojaie, Layla, et al. "Mechanisms of immune checkpoint inhibitor-mediated liver injury." Acta pharmaceutica Sinica. B vol. 11,12 (2021): 3727-3739. doi: https://doi.org/10.1016/j.apsb.2021.10.003
Shojaie L, Ali M, Iorga A, Dara L. Mechanisms of immune checkpoint inhibitor-mediated liver injury. Acta Pharm Sin B. 2021 Dec;11(12):3727-3739. doi: 10.1016/j.apsb.2021.10.003. Epub 2021 Oct 16. PMID: 35024302; PMCID: PMC8727893.
Copy
Download .nbib